If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 355.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 4.00 (1.13%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 355.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - BANK OF CYPRUS HOLDINGS PLC

23 Sep 2022 07:00

RNS Number : 3753A
Barclays PLC
22 September 2022
 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES

REPRESENTING 1% OR MORE

1.

KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

BANK OF CYPRUS HOLDINGS PLC

Class of relevant security to which the

€0.10 ordinary shares

dealings being disclosed relate (Note 2)

Date of dealing

21 September 2022

2.

INTERESTS AND SHORT POSITIONS

(a)

Interests and short positions (following dealing) in the class of relevant security

 

dealt in (Note 3)

 

Class of relevant security:

€0.10 ordinary shares

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

16,745,345

3.75%

0

0.00%

(2)

Derivatives (other than options):

0

0.00%

16,742,732

3.75%

(3)

Options and agreements to

purchase/sell:

0

0.00%

0

0.00%

TOTAL:

16,745,345

3.75%

16,742,732

3.75%

(b)

Interests and short positions in relevant securities of the company,

 

other than the class dealt in

 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

(2)

Derivatives (other than options):

(3)

Options and agreements to

purchase/sell:

TOTAL:

3.

DEALINGS (Note 4)

(a)

Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

8,060

1.3100 GBP

Purchase

24,000

1.2600 GBP

Sale

8,060

1.3100 GBP

Sale

24,000

1.2600 GBP

(b)

Derivatives transactions (other than options)

 

Product Name

Nature of transaction

Number of relevant securities

Price per unit

(c)

Options transactions in respect of existing securities

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

date

money

relevant

selling,

securities

per unit

paid/

security

varying etc

to which

received

option

per unit

relates

(ii)

Exercising

 

Product name

Number of

Exercise price per

securities

unit

(d)

Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

Details

Price per unit (if

applicable)

4.

OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing

and any other person relating to the voting rights of any relevant securities under any option

referred to on this form or relating to the voting rights or future acquisition or disposal of any

relevant securities to which any derivative referred to on this form is referenced. If none, this

should be stated.

NONE

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

22 Sep 2022

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISELTMRTMTJTBTT
Date   Source Headline
3rd Jul 202311:48 amRNSBuyback of Additional Tier 1 Capital Securities
23rd Jun 202312:48 pmRNSComposition of the Boards of Directors
20th Jun 202312:22 pmRNSResults of Additional Tier 1 Tender Cash Offer
19th Jun 202312:34 pmRNSTR1 Notification of Major Holdings - Caius
13th Jun 20233:43 pmRNSRefinancing of AT1 Capital Securities
12th Jun 202311:36 amRNSPDMR Notification of Transaction – Iordanou
12th Jun 20239:40 amRNSLaunch of Cash Tender Offer for AT1 Cap.Securities
12th Jun 20238:39 amRNSPDMR Notification of Transaction – Iordanou
8th Jun 20239:01 amRNSDoc re. (Investor Presentation Update)
8th Jun 20239:00 amRNSAnnouncement for the Investor Update Event
30th May 20237:00 amRNSTR1 Notification of Major Holdings -Eaton Vance
26th May 20235:57 pmRNSResult of AGM-Replacement
26th May 202312:41 pmRNSBoard Election and Board Committees composition
26th May 202312:35 pmRNSResolutions of AGM
16th May 20237:01 amRNSDoc re. (1Q2023 Investor Presentation)
16th May 20237:00 amRNS1Q2023 Group Financial Results
11th May 20238:56 amRNSInvestor Update event scheduled for 8 June 2023
9th May 202312:24 pmRNSAppointment of Additional Corporate Broker
5th May 20239:16 amRNSDate of announcement of 1Q2023 FR
25th Apr 202310:52 amRNSNotice of AGM 2023
19th Apr 20237:06 amRNSTR1 Notification of Holdings -Eaton Vance
13th Apr 20231:44 pmRNSResumption of dividend payments
5th Apr 202311:51 amRNSDoc re. (2022 Pillar 3 Disclosures)
3rd Apr 202310:07 amRNSChanges in the composition of the Boards
31st Mar 202312:54 pmRNSBOC Annual Financial Report 2022 Announcement
31st Mar 202312:50 pmRNSBOCH Annual Financial Report 2022 Announcement
31st Mar 202312:49 pmRNSFY2022 Group Financial Results
31st Mar 202312:46 pmRNSDoc re. (FY2022 Investor Presentation)
21st Mar 202311:02 amRNSDate of announcement of the Audited FR FY2022
20th Feb 202312:12 pmRNSNomination for appoint. to the Board of Directors
20th Feb 20237:04 amRNSPreliminary FY2022 Group Financial Results
20th Feb 20237:02 amRNSDoc re. (Prelim FY2022 Investor Presentation)
8th Feb 20237:04 amRNSAppointment of Additional Corporate Broker
3rd Feb 202310:51 amRNSDate of announcement of PrelimFY2022 FR
9th Jan 20237:00 amRNSTR1 Notification of Major Holdings -Senvest
30th Dec 20227:33 amRNSLong Term Incentive Plan
23rd Dec 20229:15 amRNSPDMR Notification of Transaction – Iordanou
16th Dec 20221:54 pmRNSExtension of appointment of Group CEO
16th Dec 20228:05 amRNSDate of Annual General Meeting
12th Dec 20227:14 amRNSEU-wide Transparency Exercise 2022
30th Nov 20227:28 amRNSChange in the composition of the Board Committees
25th Nov 20229:36 amRNSPDMR Notification of Transaction – Arapoglou
24th Nov 20229:13 amRNSPDMR Notification of Transaction – Arapoglou
23rd Nov 20229:12 amRNSPDMR Notification of Transaction – Arapoglou
22nd Nov 202210:20 amRNSPDMR Transaction - Arapoglou
18th Nov 202210:26 amRNSCompletion of Project Helix 3
18th Nov 20227:01 amRNS9M2022 Investor Presentation Announcement
18th Nov 20227:00 amRNS9M2022 Group Financial Results
16th Nov 20229:01 amRNSBOCH Explanation following its AGM on 20 May 2022
4th Nov 20229:09 amRNSDate of announcement of 9M2022 FR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.